Bourne Steven A. 4
4 · Clarus Therapeutics Holdings, Inc. · Filed Sep 13, 2021
Insider Transaction Report
Form 4
Bourne Steven A.
Chief Administrative Officer
Transactions
- Award
Common Stock
2021-09-09+1,305→ 1,305 total
Footnotes (1)
- [F1]Received pursuant to the Agreement and Plan of Merger, dated as of April 27, 2021 by and among Blue Water Acquisition Corp. (n/k/a Clarus Therapeutics Holdings, Inc.) (the "Issuer"), Blue Water Merger Sub Corp. and Clarus Therapeutics, Inc. ("Legacy Clarus") (the "Merger Agreement") pursuant to which, through a merger, Legacy Clarus became a direct, wholly-owned subsidiary of the Issuer.